Literature DB >> 23121375

Trials in kidney disease--time to EVOLVE.

Vlado Perkovic, Bruce Neal.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23121375     DOI： 10.1056/NEJMe1212368

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Controversial results from the EVOLVE trial.

Authors: 
Journal:  Bonekey Rep       Date:  2013-01-30

Review 2.  Calciphylaxis: risk factors, diagnosis, and treatment.

Authors:  Sagar U Nigwekar; Daniela Kroshinsky; Rosalynn M Nazarian; Jeremy Goverman; Rajeev Malhotra; Vicki Ann Jackson; Mihir M Kamdar; David J R Steele; Ravi I Thadhani
Journal:  Am J Kidney Dis       Date:  2015-05-07       Impact factor: 8.860

3.  Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

Authors:  Francesca Tentori; Mia Wang; Brian A Bieber; Angelo Karaboyas; Yun Li; Stefan H Jacobson; Vittorio E Andreucci; Masafumi Fukagawa; Luc Frimat; David C Mendelssohn; Friedrich K Port; Ronald L Pisoni; Bruce M Robinson
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-16       Impact factor: 8.237

4.  Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.

Authors:  Kevin F Erickson; Glenn M Chertow; Jeremy D Goldhaber-Fiebert
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

5.  Glomerular Diseases: Registries and Clinical Trials.

Authors:  Marva M Moxey-Mims; Michael F Flessner; Lawrence Holzman; Frederick Kaskel; John R Sedor; William E Smoyer; Aliza M Thompson; Lynne Yao
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-26       Impact factor: 8.237

6.  Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease.

Authors:  Julia J Arnold; Manvir Hayer; Adnan Sharif; Irena Begaj; Mohammed Tabriez; David Bagnall; Daniel Ray; Ciaron Hoye; Masood Nazir; Mary Dutton; Lesley Fifer; Katie Kirkham; Don Sims; Jonathan N Townend; Paramjit S Gill; Indranil Dasgupta; Paul Cockwell; Charles J Ferro
Journal:  BMJ Open       Date:  2015-05-03       Impact factor: 2.692

Review 7.  Managing hyperparathyroidism in hemodialysis: role of etelcalcetide.

Authors:  Keith E Eidman; James B Wetmore
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-02-05

8.  Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study.

Authors:  Patricia Taschner Goldenstein; Rosilene Motta Elias; Lilian Pires de Freitas do Carmo; Fernanda Oliveira Coelho; Luciene Pereira Magalhães; Gisele Lins Antunes; Melani Ribeiro Custódio; Fábio Luiz de Menezes Montenegro; Silvia Maria Titan; Vanda Jorgetti; Rosa Maria Affonso Moysés
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 9.  Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease.

Authors:  Kristen L Jablonski; Michel Chonchol
Journal:  F1000Prime Rep       Date:  2014-08-01

10.  PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism.

Authors:  Tadao Akizawa; Noriaki Kurita; Masahide Mizobuchi; Masafumi Fukagawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Alan R Ellis; Shingo Fukuma; M Alan Brookhart; Takeshi Hasegawa; Kiyoshi Kurokawa; Shunichi Fukuhara
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.